Sbi Securities Co., Ltd. Roivant Sciences Ltd. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 1,285 shares of ROIV stock, worth $14,096. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,285Holding current value
$14,096% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
320Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$723 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$722 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$593 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$457 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$388 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.73B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...